Skip to content

PP&E (Net) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$7.66B+6.2%
Cytokinetics logo
CytokineticsCYTK
$82.44M+22.7%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$52.74M-11.3%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$994K-19.8%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$23.68M+312%
Scholar Rock logo
Scholar RockSRRK
$1.44M-45.6%

Other financials

Income statement

See full
Operating income-$54.1M-17.7%
Net income-$49.0M-20.1%
EPS (diluted)-$0.46-7.0%

Balance sheet

See full
Cash & equivalents$33.2M-33.5%
Total debt$3.8M-16.8%
Total equity$493.2M+14.8%
Total assets$518.5M+14.1%

Cash flow

See full
Operating cash flow-$42.5M-12.4%
CapEx$260.0K+491%
Free cash flow-$42.8M-12.9%

Valuation

See full
Market cap$3.96B+61.3%
Enterprise value$3.93B+63.5%

Returns & leverage

See full
Return on equity-38.1%+13.4pp
Debt / equity0.0×
Current ratio22.6×+1.6×

Where this comes from

Reported directly by Edgewise Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edgewise Therapeutics, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Edgewise Therapeutics, Inc.'s PP&E (net)?
Edgewise Therapeutics, Inc. (EWTX) reported PP&E (net) of $7.4M in Q1 2026.
How has Edgewise Therapeutics, Inc.'s PP&E (net) changed year-over-year?
Edgewise Therapeutics, Inc.'s PP&E (net) decreased by 17.7% year-over-year, from $8.99M to $7.4M.
What is the long-term trend for Edgewise Therapeutics, Inc.'s PP&E (net)?
Over 5 years (2020 to 2025), Edgewise Therapeutics, Inc.'s PP&E (net) has grown at a 72.3% compound annual growth rate (CAGR), from $516K to $7.83M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.